Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SKYE is expected to report earnings to fall 30.09% to -150 cents per share on March 25
Q4'26
Est.
$-1.51
Q2'26
Missed
by $0.18
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Missed
by $0.09
The last earnings report on August 14 showed earnings per share of -216 cents, missing the estimate of -198 cents. With 6.18K shares outstanding, the current market capitalization sits at 7.22M.